Meconium: Biomarker Vehicle of Expusure to Psychoactive Substances in Pregnant Women

Manrrique Lopez, Sandra; Orjuela Velasco, Milena; Puentes Garcia, Sonia

dc.creator	Manrrique Lopez, Sandra
dc.creator	Orjuela Velasco, Milena
dc.creator	Puentes Garcia, Sonia
dc.date	2007-06-15
dc.date.accessioned	2019-11-08T21:24:46Z
dc.date.available	2019-11-08T21:24:46Z
dc.identifier	http://hemeroteca.unad.edu.co/index.php/nova/article/view/377
dc.identifier	10.22490/24629448.377
dc.identifier.uri	https://repository.unad.edu.co/handle/10596/29954
dc.description	Children exposed to drugs in a prenatal way are a medical and social problem. A useful way to study this problem is by analyzing biological matrices, such as the meconium, which stores psychoactive substances or their metabolites. To determine its fetal exposure the most common system is the analysis of blood from the umbilical cord, urine from the mother, or urine from the new born. Meconium is inert and it is easily obtainable. It stores psychoactive substances or its metabolites from week 12 of gestation and they are fossilized in it until birth. It can be a very important instrument to investigate fetal exposure to several drugs of abuse. It is necessary to know the degree of fetal exposure to contribute to the prognosis and timely pathology treatment which, due to the lack of clinical relevant manifestations, can be overlooked and require the implementation of tests that use reliable biological matrices.	en-US
dc.description	La población infantil expuesta prenatalmente a drogas de abuso constituye un problema médico-social. Una forma útil de abordar este problema consiste en analizar matrices biológicas, como el meconio, que acumula sustancias psicoactivas o sus metabolitos. Su determinación de la exposición fetal se ha centrado en el análisis de sangre de cordón u orina materna o neonatal. El meconio es inerte y de fácil obtención, acumula sustancias psicoactivas o sus metabolitos desde la semana 12 de gestación donde quedan fosilizados hasta el nacimiento. Puede constituir un instrumento muy importante para investigar la exposición fetal a distintas drogas de abuso. Es necesario conocer el grado de exposición fetal para contribuir al diagnóstico y al tratamiento oportuno de patologías que por falta de manifestaciones clínicas relevantes, pasan inadvertidas y requieren la implementación de pruebas que utilicen matrices biológicas confiables.	es-ES
dc.format	application/pdf
dc.language	spa
dc.publisher	Universidad Colegio Mayor de Cundinamarca	es-ES
dc.relation	http://hemeroteca.unad.edu.co/index.php/nova/article/view/377/1179
dc.relation	/ref/Kaloðlu C, Gürsoy E, Onarlioðlu B. Early maternal changes contributing to the formation of the chorioallantoic and yolk sac placentas in rat: a morphological study. Anat Histol Embryol. 2003;32:200-206. 2. A. C. Enders A, Carter A. What Can Comparative Studies of Placental Structure Tell Us?—A Review Placenta 2004; 25:S3-S9. 3. Burton G, Jauniaux E, Charnock-Jones D. Human Early Placental Development: Potential Rolesof the Endometrial Glands. Placenta. 2007;21:S64-S69. 4. Weissgerber T, Wolfe L. Physiological adaptation in early human pregnancy: adaptation to balance maternal-fetal demands. Appl Physiol Nutr Metab. 2006;31:1-11 5. Myren M, Mose T, Mathiesen L, Knudsen L. The human placenta-An alternative for studying foetal exposure. Toxicol In Vitro. 2007; 7: [Epub ahead of print]. 6. Ortega J., Carrizo D, Ferris J, Peinador M, Grimalt J. Meconium and neurotoxicans. Revista Española De Pediatría. 2004,60:291-296. 7. Mur A, García O, López N. Toxicidad de la cocaína en el recién nacido. Detección y prevalencia. An Esp Pediatr 2002;56:241-246 8. Ostrea E, Knapp D, Tannenbaum L, Ostrea A, Romero A, Salari V, Ager J. Estimates of illicit drug use during pregnancy by maternal interview, hair analysis, and meconium analysis. J Pediatr 2001;138:344-348. 9. Doris J, Meguid V, Thomas M, Blatt S, Eckenrode J. Prenatal cocaine exposure and child welfare outcomes. Child Maltreat. 2006;11:326-337. 10. Lewis D, Moore C, Leikin J, Koller A. Meconium analysis for cocaine: a validation study and comparison with paired urine analysis. J Anal Toxicology. 1995;19:148-150. 11. Kapusta N, Plener P, Schmid R, Thau K, Walter H, Lesch O. Multiple substance use among young males. Pharmacol Biochem Behav. 2007;86:306-311. 12. Schuetze P, Eiden R, Coles C. Prenatal cocaine and other substance exposure: effects on infant autonomic regulation at 7 months of age. Dev Psychobiol. 2007;49:276-89 13. Shankaran S, Lester B, Das A, Bauer C, Bada H, Lagasse L, Higgins R. Impact of maternal substance use during pregnancy on childhood outcome. Semin Fetal Neonatal Med. 2007;12:143-50. 14. Periódico El Tiempo. El Consumo De Alcohol, Marihuana, Cocaína Y Basuco Está ‘Disparado’ En Bogotá. Julio 31 De 2006. 15. Gauthier T, Manar M, Brown L. Is maternal alcohol use a risk factor for early-onset sepsis in premature newborns? Alcohol. 2004;33:139-145. 16. Nelson S, Lerner E, Needlman R, Salvator A, Singer L. Cocaine, anemia, and neurodevelopmental outcomes in children: a longitudinal study. J Dev Behav Pediatr. 2004;25:1-9. 17. Herlenius E, Lagercrantz H. Neurotransmitters and neuromodulators during early development. Early Hum Dev 2001;65:21-37. 18. Stanwood G, Levitt P. Prenatal exposure to cocaine produces unique developmental and long-term adaptive changes in dopamine D1 receptor activity and subcellular distribution. J Neurosci. 2007;27:152-157. 19. Tapia J, Ventura P. Manual de neonatología. Edt. Mediterráneo. Santiago de Chile. 2000. 20. Vigilancia Epidemiológica Del Consumo De SPA En Bogota, Estadísticas, 2001, 2004, 2005, 2006. Secretaria Distrital De Salud. 21. Velasquez. J. Farmacología y Toxicología Clínica. Ed. Panamericana 2005, 384–392
dc.rights	Copyright (c) 2007 NOVA Publicación en Ciencias Biomédicas	es-ES
dc.rights	http://creativecommons.org/licenses/by/4.0	es-ES
dc.source	NOVA Biomedical Sciences Journal; Vol. 5, Núm. 7 (2007); 76-83	en-US
dc.source	Nova; Vol. 5, Núm. 7 (2007); 76-83	es-ES
dc.source	NOVA Ciências Biomédicas Publicação; Vol. 5, Núm. 7 (2007); 76-83	pt-BR
dc.source	2462-9448
dc.source	1794-2470
dc.subject	Ciencias Médicas y de la Salud,Medicina Clínica,Otros Temas de Medicina Clínica	es-ES
dc.subject	cocaína; etanol; marihuana, meconio; retardo del crecimiento fetal; síndrome alcohólico fetal; síndrome de abstinencia neonatal.	es-ES
dc.subject	cocaine; etanol; fetal growth retardation fetal alcohol syndrome; marijuana; meconium; neonatal abstinence syndrome.	en-US
dc.title	Meconium: Biomarker Vehicle of Expusure to Psychoactive Substances in Pregnant Women	en-US
dc.title	Meconio: vehiculo de biomarcadores de exposición a sustancias psicoactivas en gestantes	es-ES
dc.type	info:eu-repo/semantics/article
dc.type	info:eu-repo/semantics/publishedVersion
dc.type	reviewArticle	en-US
dc.type	reviewArticle	es-ES
dc.type	reviewArticle	pt-BR